JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
JBI Evid Synth. 2023 Mar 1;21(3):584-591. doi: 10.11124/JBIES-22-00317.
The objective of this methodological review is to evaluate the adherence of systematic reviews of effectiveness published in JBI Evidence Synthesis to reporting guidelines and methodological quality.
Systematic reviews of effectiveness are essential tools for health practitioners and policy-makers. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines and the Risk of Bias in Systematic Reviews (ROBIS) tool are used to ensure maintenance of high reporting standards and methodological quality, respectively. This review will utilize these tools to identify strengths and shortfalls in the reporting quality of JBI systematic reviews of effectiveness.
This review will include the 20 most recent systematic reviews of effectiveness published in JBI Evidence Synthesis .
This review will search MEDLINE (PubMed) for effectiveness reviews published in JBI Evidence Synthesis . Abstract and full-text screening will be performed by 2 independent reviewers, and the most recent 20 studies will be selected for inclusion. Data regarding adherence to PRISMA 2020 and ROBIS will be extracted by 2 independent reviewers. Data will be presented descriptively with tables and synthesized narratively.
本方法学综述的目的是评估发表在 JBI 证据综合中的有效性系统评价对报告指南和方法学质量的遵循情况。
有效性系统评价是卫生保健从业者和政策制定者的重要工具。首选报告项目用于系统评价和荟萃分析(PRISMA)2020 指南和系统评价偏倚风险(ROBIS)工具分别用于确保维持高标准的报告和方法学质量。本综述将利用这些工具来确定 JBI 有效性系统评价报告质量的优势和不足。
本综述将包括发表在 JBI 证据综合中的最近的 20 篇有效性系统评价。
本综述将在 MEDLINE(PubMed)中搜索发表在 JBI 证据综合中的有效性评价。由 2 名独立评审员进行摘要和全文筛选,选择最近的 20 项研究进行纳入。由 2 名独立评审员提取关于对 PRISMA 2020 和 ROBIS 的遵循情况的数据。数据将以表格形式呈现,并进行叙述性综合。